SCHEMBL5782008

SCHEMBL5782008

OCc1c[c]ccc1C(F)(F)F

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.33
IDO1 P14902 2/20 0.32
HSP90AA1 P07900 1/20 0.30
HSP90AB1 P08238 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14895318 0.86 KIF11 (0.33) KIF11HSP90AA1HSP90AB1
SCHEMBL5688271 0.80 AR (0.34) IDO1
SCHEMBL27719883 0.80 IDO1 (0.36) IDO1
SCHEMBL146460 0.73 AR (0.31)
SCHEMBL156028 0.73 APOBEC3G (0.31)
SCHEMBL1477305 0.72
SCHEMBL1519797 0.72 AR (0.32) KIF11
SCHEMBL21433967 0.72 EPHX2 (0.32)
SCHEMBL44837 0.72 IDO1 (0.57) IDO1
SCHEMBL29389277 0.72 IDO1 (0.57) IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1670794-A2 VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS Amgen Inc. (US) 2006-06-21 EP disclosed
WO-2005033105-A2 VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS AMGEN INC. (US) 2005-04-14 WO disclosed